#Sunitinib hashtag - Bluesky

@liferaftgroup.bsky.social

2 months ago

Last chance! If you’ve taken #Sutent or the generic #sunitinib, don’t miss the opportunity to contribute to this research survey. Your voice matters to the future of research!! bit.ly/sunitinib-su...
#GISTresearch #PatientVoices #rarecancer

1 0 0 0

Stem Cell Podcast

@stemcellpodcast.com

3 months ago

#Sunitinib is an effective cancer treatment, but can cause #hypertension & #HeartFailure.

Drs. Amit Manhas, Yu Liu, & Dr. Nazish Sayed at @stanfordcvi.bsky.social restored #PIEZO1 expression to reverse sunitinib-induced #endothelial dysfunction.

🔖 https://bit.ly/4s9xrBG
🗨️ https://bit.ly/4p3izlj

2 0 0 0

The Life Raft Group - GIST Support

@liferaftgroup.bsky.social

3 months ago

Share your voice and help improve patient support by completing the #Sutent survey (only for patients who are on Sutent/sunitinib or have taken it in the past).
Take the survey: bit.ly/sunitinib-su...
#Sunitinib #PatientVoices #GISTcommunity #GIST

0 0 0 0

Molecular Biomedicine

@mol-biomed.bsky.social

3 months ago

Fibroblasts promote the progression of benign prostatic hyperplasia through colony-stimulating factor 1 receptor-mediated RTK signaling in prostatic epithelial cells - Molecular Biomedicine Benign prostatic hyperplasia (BPH) is a prevalent condition characterized by nonmalignant proliferation of epithelial and stromal components in the prostate, frequently resulting in lower urinary trac...

#Research
Fibroblasts promote the progression of benign prostatic hyperplasia through colony-stimulating factor 1 receptor-mediated RTK signaling in prostatic epithelial cells doi.org/10.1186/s435...

#BenignProstaticHyperplasia #Fibroblasts #Sunitinib #RTK #Signaling #CSF1R

0 0 0 0

The Life Raft Group - GIST Support

@liferaftgroup.bsky.social

4 months ago

Your experience matters! For those who have taken #sunitinib for #GIST - by sharing what treatment has been like for you, you can help other patients and shape better care for the future.
Take this brief survey: bit.ly/sunitinib-su...
#DataMatters #GISTresearch

0 0 0 0

Fondation ARC pour la recherche sur le cancer

@fondationarc.bsky.social

5 months ago

Des chercheurs à l'IRCAN ont découvert qu’en bloquant la production de sérine, un acide aminé favorisant la résistance tumorale, on peut re-sensibiliser le #CancerDuRein au traitement #Sunitinib. Cette découverte pourrait aussi aider à traiter d’autres cancers résistants.
ow.ly/3gAn50XlO10

0 0 0 0

The Life Raft Group - GIST Support

@liferaftgroup.bsky.social

5 months ago

What about- Did you know? There is an Expanded Access Program that gives advanced GIST patients who’ve progressed on imatinib access to #bezuclastinib + #sunitinib. For more information: bit.ly/CB-EAP
#EAP #GISTEducation #ExpandedAccessProgram #clinicaltrials

1 0 0 0

Bibliosalut

@bibliosalut.bsky.social

10 months ago

#PublicaSalutIB Hematologia de Son Espases ha participat en un assaig sobre l'ús del Nivolumab i sunitinib en pacients amb sarcomes ossis avançats www.infosalut.com/investigacio/estudis-i-p... https://doi.org/10.1002/cncr.35628

#hematologia #nivolumab #sunitinib #sarcomesossis

0 0 0 0

Onco404

@onco404.bsky.social

10 months ago

With mature OS data, ripretinib demonstrates comparable survival to sunitinib with a better long-term safety profile in second-line advanced GIST.

#Onco404 #Cancer #Kanser #GIST #Ripretinib #Sunitinib #ClinicalTrials #MedSky #OncSky

1 0 0 0

Onco404

@onco404.bsky.social

10 months ago

📊 Key Findings
✅ Median OS (overall population): 35.5 vs. 31.5 months (ripretinib vs. sunitinib; HR 0.86).
☑️ KIT exon 11 subgroup: 35.5 vs. 32.8 months (HR 0.98).

#Onco404 #Cancer #Kanser #GIST #Ripretinib #Sunitinib #ClinicalTrials #MedSky #OncSky

1 0 1 0

Onco404

@onco404.bsky.social

10 months ago

The final analysis of the INTRIGUE phase III trial reveals ripretinib and sunitinib show comparable overall survival in advanced GIST patients post-imatinib.

@ascocancer.bsky.social #JCO #ASCO

#Onco404 #Cancer #Kanser #GIST #Ripretinib #Sunitinib #ClinicalTrials #MedSky #OncSky